Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 3/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRB | P28702 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium SCHEMBL8009526 | 0.98 | LMNA (0.41) | LMNASMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL30241159 | 0.83 | CYP2A6 (0.40) | LMNASMN1; SMN2TSHRKMT2AALDH1A1 | |
| SCHEMBL29544564 | 0.82 | TSHR (0.43) | SMN1; SMN2TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL6680350 | 0.82 | TSHR (0.43) | SMN1; SMN2TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL29706601 | 0.82 | ENPP2 (0.44) | LMNASMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL6678412 | 0.82 | ENPP2 (0.44) | LMNASMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL17602712 | 0.80 | TSHR (0.37) | LMNASMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL738763 | 0.80 | TSHR (0.45) | LMNASMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL30984399 | 0.79 | CYP1A2 (0.52) | LMNASMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL27570492 | 0.79 | ENPP2 (0.41) | LMNASMN1; SMN2TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1745280-B1 | POTENTIOMETRIC ELECTRODE WITH A GRADIENT POLYMER COMPRISING CONDUCTIVE PARTICLES AND IONOPHORE MOLECULES, ITS MANUFACTURE AND USE | PION INC (US) | 2022-09-07 | — | — | EP | claimed |
| US-7857962-B2 | Potentiometric electrode, gradient polymer, uses and method of preparation therefor | UNIVERSITEIT ANTWERPEN (BE) | 2010-12-28 | — | — | US | claimed |
| EP-1745280-A2 | POTENTIOMETRIC ELECTRODE WITH A GRADIENT POLYMER COMPRISING CONDUCTIVE PARTICLES AND IONOPHORE MOLECULES | AIC (BE) | 2007-01-24 | — | — | EP | claimed |
| WO-2005103664-A2 | POTENTIOMETRIC ELECTRODE WITH A GRADIENT POLYMER COMPRISING CONDUCTIVE PARTICLES AND IONOPHORE MOLECULES | AIC (BE) | 2005-11-03 | — | — | WO | claimed |
| CN-122094955-A | Compound, light-emitting device, display device, electronic apparatus, and lighting device | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122036692-A | Quinazoline compound, precursor, derivative and application thereof | 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) | 2026-05-15 | — | — | CN | disclosed |
| CN-120202207-A | Compound for organic electric element, organic electric element using the same, and electronic device using the same | 德山新勒克斯有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-119331001-B | Efficient narrow-band luminescent material embedded with dibenzothiophene, and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2025-06-10 | — | — | CN | disclosed |
| CN-114072393-B | 3-Amino-4H-benzo [ E ] [1,2,4] thiadiazine 1, 1-dioxide derivatives as MRGX2 inhibitors | 索伦特治疗有限责任公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-120005686-A | Composition comprising lipase and sulfite | 诺维信公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-116332914-B | Compound for organic electric element, organic electric element using the same, and electronic device using the same | 德山新勒克斯有限公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-115023414-B | Compound for organic electronic element, organic electronic element using the same, and electronic device using the same | 德山新勒克斯有限公司 | 2025-03-28 | — | — | CN | disclosed |
| EP-0675118-B1 | Biphenylderivatives, process for their preparation and their use as medicaments | EISAI CO LTD (JP) | 2002-10-09 | — | — | EP | disclosed |
| US-6455720-B1 | AS CATALYSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-24 | — | — | US | disclosed |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| EP-1167372-A1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1137641-A1 | PROCESS FOR PREPARING PYRIDAZIN-3-ON DERIVATIVES | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2001-10-04 | — | — | EP | disclosed |
| US-6281214-B1 | USEFUL FOR TREATING AND AMELIORATING MENTAL DISORDERS | EISAI CO., LTD (JP) | 2001-08-28 | — | — | US | disclosed |
| WO-2000034249-A1 | PROCESS FOR PREPARING PYRIDAZIN-3-ON DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-06-15 | — | — | WO | disclosed |
| EP-0675118-A2 | Biphenylderivatives, process for their preparation and their use as medicaments | Eisai Co., Ltd. (JP) | 1995-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | DDT, PDCD11, PLD2 | LMNA 4620/4885SMN1; SMN2 4274/4885TSHR 2225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.